Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
FRESENIUS KABI USA, LLC v. FERA PHARMACEUTICALS, LLC, et al
Case Number:
2:15-cv-03654
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 18, 2016
Fera Taking Loss Over Thyroid Drug Generic To Fed. Circ.
Fera Pharmaceuticals LLC on Tuesday told a New Jersey federal court that it will be asking the Federal Circuit to overturn the court's order barring the drug company from making a generic of Fresenius Kabi USA LLC's levothyroxine-based thyroid medication.
-
September 21, 2016
Fresenius Scores Preliminary Injunction In Drug Patent Case
A New Jersey federal judge on Tuesday granted Fresenius Kabi USA LLC a rare preliminary injunction barring Fera Pharmaceuticals LLC from launching a generic version of a drug used to treat patients without a properly functioning thyroid.